HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow Reinvestment Rate
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow Reinvestment Rate of 0.02x as of June 2025, reinvesting CN¥3.09 Million (capex CN¥1.55 Million plus investments CN¥-1.55 Million) from operating cash flow of CN¥176.16 Million. Check cash flow quality index of HPGC Renmintongtai Pharmaceutical Corp to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HPGC Renmintongtai Pharmaceutical Corp Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for HPGC Renmintongtai Pharmaceutical Corp across 22 annual periods. Explore HPGC Renmintongtai Pharmaceutical Corp (600829) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year capital reinvestment analysis for HPGC Renmintongtai Pharmaceutical Corp. For live market cap and broader valuation context, see HPGC Renmintongtai Pharmaceutical Corp market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥17.16 Million | CN¥299.98 Million | CN¥17.16 Million | ▼ -58.6% |
| 2024 | 0.14x | CN¥15.94 Million | CN¥115.44 Million | CN¥8.04 Million | ▼ -77.4% |
| 2023 | 0.61x | CN¥203.34 Million | CN¥332.99 Million | CN¥23.48 Million | ▲ +1427.4% |
| 2022 | 0.04x | CN¥12.29 Million | CN¥307.33 Million | CN¥6.42 Million | ▲ +36.3% |
| 2018 | 0.03x | CN¥10.75 Million | CN¥366.45 Million | CN¥5.73 Million | ▼ -71.1% |
| 2017 | 0.10x | CN¥14.10 Million | CN¥139.07 Million | CN¥7.10 Million | ▼ -89.6% |
| 2016 | 0.97x | CN¥44.74 Million | CN¥46.01 Million | CN¥22.81 Million | ▲ +812.9% |
| 2015 | 0.11x | CN¥35.58 Million | CN¥333.99 Million | CN¥35.58 Million | ▲ +145.1% |
| 2014 | 0.04x | CN¥17.06 Million | CN¥392.58 Million | CN¥17.06 Million | ▼ -68.5% |
| 2012 | 0.14x | CN¥30.56 Million | CN¥221.57 Million | CN¥30.56 Million | ▼ -59.1% |
| 2010 | 0.34x | CN¥54.90 Million | CN¥162.99 Million | CN¥54.90 Million | ▲ +61.6% |
| 2009 | 0.21x | CN¥93.36 Million | CN¥447.82 Million | CN¥93.36 Million | ▼ -6.8% |
| 2007 | 0.22x | CN¥42.76 Million | CN¥191.10 Million | CN¥42.76 Million | ▼ -40.4% |
| 2006 | 0.38x | CN¥71.74 Million | CN¥191.13 Million | CN¥71.74 Million | ▲ +236.1% |
| 2005 | 0.11x | CN¥34.96 Million | CN¥313.04 Million | CN¥34.96 Million | ▼ -90.7% |
| 2004 | 1.20x | CN¥72.69 Million | CN¥60.69 Million | CN¥72.69 Million | ▼ -56.1% |
| 2003 | 2.73x | CN¥195.45 Million | CN¥71.65 Million | CN¥195.45 Million | ▲ +528.6% |
| 2002 | 0.43x | CN¥55.32 Million | CN¥127.49 Million | CN¥55.32 Million | ▼ -81.8% |
| 2001 | 2.39x | CN¥35.35 Million | CN¥14.79 Million | CN¥35.35 Million | ▲ +142.0% |
| 2000 | 0.99x | CN¥61.09 Million | CN¥61.85 Million | CN¥61.09 Million | ▲ +32.3% |
| 1999 | 0.75x | CN¥43.45 Million | CN¥58.21 Million | CN¥43.45 Million | ▲ +48.9% |
| 1998 | 0.50x | CN¥20.55 Million | CN¥41.00 Million | CN¥20.55 Million | — |